Updated Date:
24 Feb 2026
Product Detail:
XENPOZYME olipudase alfa 20mg powder for injection vial
Shortage Status:
Current
AUST R:
394103
Availability:
Limited Availability
Active Ingredient:
olipudase alfa
Reason:
Manufacturing
Dosage Form:
Injection,powderfor
Supply Impact Dates
From 24 Feb 2026
To 30 Apr 2026
Management Action:
An overseas registered product has been approved for supply under Section 19A. The approval holder, Sanofi-Aventis Australia Pty Ltd, can be contacted for details on supply on 1800 818 806.
